These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32433163)

  • 21. Value of the
    Fastrez M; Artigas C; Sirtaine N; Wimana Z; Caillet M; Rozenberg S; Flamen P
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():69-74. PubMed ID: 28342392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endolymphatic sac tumour: case report and literature review.
    Virk JS; Randhawa PS; Saeed SR
    J Laryngol Otol; 2013 Apr; 127(4):408-10. PubMed ID: 23448594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of somatostatin receptor expressing tumor volume calculated from
    Toriihara A; Baratto L; Nobashi T; Park S; Hatami N; Davidzon G; Kunz PL; Iagaru A
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2244-2251. PubMed ID: 31350603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR imaging, CT, and angiography features of endolymphatic sac tumors: report of two cases.
    Baltacioğlu F; Ekinci G; Türe U; Sav A; Pamýr N; Erzen C
    Neuroradiology; 2002 Jan; 44(1):91-6. PubMed ID: 11942507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management.
    Kunikowska J; Lewington V; Krolicki L
    Clin Nucl Med; 2017 Dec; 42(12):905-911. PubMed ID: 29076910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 68Ga-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor.
    Soydal C; Nak D; Araz M; Demirkazik A; Kucuk NO
    Clin Nucl Med; 2019 Oct; 44(10):795-796. PubMed ID: 31306201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevant Discordance Between 68Ga-DOTATATE and 68Ga-DOTANOC in SDHB-Related Metastatic Paraganglioma: Is Affinity to Somatostatin Receptor 2 the Key?
    Janssen I; Wolf KI; Chui CH; Millo CM; Pacak K
    Clin Nucl Med; 2017 Mar; 42(3):211-213. PubMed ID: 28033222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 68Ga-DOTATATE Uptake by Cervicothoracic (Stellate) Ganglia.
    Berg Z; Koppula BR
    Clin Nucl Med; 2019 Oct; 44(10):810-811. PubMed ID: 31306203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Acting Somatostatin Analog Therapy Differentially Alters
    Ayati N; Lee ST; Zakavi R; Pathmaraj K; Al-Qatawna L; Poon A; Scott AM
    J Nucl Med; 2018 Feb; 59(2):223-227. PubMed ID: 28729431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved Detection of Transosseous Meningiomas Using
    Kunz WG; Jungblut LM; Kazmierczak PM; Vettermann FJ; Bollenbacher A; Tonn JC; Schichor C; Rominger A; Albert NL; Bartenstein P; Reiser MF; Cyran CC
    J Nucl Med; 2017 Oct; 58(10):1580-1587. PubMed ID: 28450556
    [No Abstract]   [Full Text] [Related]  

  • 31. 68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region.
    Dadgar H; Norouzbeigi N; Ahmadzadehfar H; Assadi M
    Clin Nucl Med; 2020 Aug; 45(8):e363-e364. PubMed ID: 32558717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenocarcinoma of the endolymphatic sac: imaging features and preoperative embolization.
    Mukherji SK; Castillo M
    Neuroradiology; 1996 Feb; 38(2):179-80. PubMed ID: 8692436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicoradiologic characteristics of endolymphatic sac tumors.
    Le H; Zhang H; Tao W; Lin L; Li J; Ma L; Hong G; Lou X
    Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2705-2714. PubMed ID: 31197530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cystic mass in left temporal bone].
    Xiong J; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):198-9. PubMed ID: 19575859
    [No Abstract]   [Full Text] [Related]  

  • 35. (68)Ga-DOTATATE PET in juvenile angiofibroma.
    Gronkiewicz Z; Kukwa W; Krolicki L; Cyran-Chlebicka A; Pawlak D; Stankiewicz C; Krzeski A; Górnicka B; Wolosz D; Kunikowska J
    Future Oncol; 2016 Jun; 12(12):1483-91. PubMed ID: 26971784
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Şimşek DH; Şanlı Y; Kuyumcu S; Başaran B; Mudun A
    Ann Nucl Med; 2018 May; 32(4):297-301. PubMed ID: 29468487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretory IgA in the endolymphatic sac tumour.
    Körner M; Linder T; Gebbers JO
    Histopathology; 2003 Jan; 42(1):98-9. PubMed ID: 12493036
    [No Abstract]   [Full Text] [Related]  

  • 39. Endolymphatic sac tumor (low-grade papillary adenocarcinoma) of the temporal bone.
    Devaney KO; Ferlito A; Rinaldo A
    Acta Otolaryngol; 2003 Dec; 123(9):1022-6. PubMed ID: 14710902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
    Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
    J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.